Search

This edition examines the role of news influencers in spreading misinformation, misleading narratives about harm reduction amid disparities in opioid overdose, and biases in artificial intelligence (AI) in healthcare.

This fact sheet explains the U.S. government’s role in addressing the global tuberculosis epidemic, including the history of U.S. involvement and funding trends.

This brief reviews some of the possible actions of the incoming Trump administration and new Congress based on campaign statements, policies implemented by the first Trump administration, and proposals forwarded by allied conservative think tanks and antiabortion advocacy groups.

The Centers for Medicare & Medicaid Services (CMS) recently announced the drugs selected for the second round of negotiation for the Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and CMS’s implementation of the program, with a focus on the details that apply for 2027, the second year that negotiated prices will be available under the program.